33.50 -0.49 (-1.44%)
After hours: 5:55PM EDT
|Bid||34.06 x 1200|
|Ask||34.04 x 1400|
|Day's range||33.97 - 34.75|
|52-week range||24.47 - 34.75|
|Beta (3Y monthly)||0.19|
|PE ratio (TTM)||16.63|
|Earnings date||29 Oct. 2019 - 4 Nov. 2019|
|Forward dividend & yield||1.48 (4.27%)|
|1y target est||34.07|
The latest unveiling of Public Storage's (PSA) storage units in Murfreesboro comes as part of the company's effort to expand in this region which has been witnessing rapid growth of the neighborhood.
Boston Properties (BXP) will redeem its outstanding 5.625% senior notes due in 2020 by using proceed raised from sale of 2.9% senior notes, which will likely result in interest saving.
HCP's efforts to expand its medical office and life-science portfolio, a diversified and high-quality portfolio and favorable demographic trends make it an attractive pick.
HCP (HCP) delivered FFO and revenue surprises of 2.33% and 9.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Focus on life-science and MOB portfolio will likely enable HCP to witness decent growth in Q2. However, prevalent challenges in the senior housing market are a spoilsport.
Is HCP, Inc. (NYSE:HCP) a good dividend stock? How can we tell? Dividend paying companies with growing earnings can be...
Acquisition of seniors housing portfolio valued at $1.8 billion, including construction in progress, will likely help Ventas (VTR) in diversifying its assets, business model and operator base.
HCP's amended and restated credit helps increase the size of the facility, extend the maturity date, lower the borrowing costs and boost financial flexibility.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock...
HCP's first-quarter 2019 results indicate decent performance of the company's life-science and medical-office segments. Yet, tepid performance of seniors-housing portfolio remains a drag.
HCP (HCP) delivered FFO and revenue surprises of 2.33% and -1.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
HCP's premium MOB and life-sciences portfolio will likely perform well in first-quarter 2019, mitigating the challenges tormenting the senior housing market.